613 — Atlanta, Georgia

613 is a clinical research site located in Atlanta, Georgia, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

613 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB BIOSCIENCES, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 613?

613 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 613 conducted?

613 has 1 clinical trials on record. Their work covers Epilepsy.

Is 613 accredited by Crixeo Health?

613 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 613?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.